Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Teva Pharmaceutical Industries Ltd (TEVA)

Teva Pharmaceutical Industries Ltd (TEVA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 10,154,726
  • Shares Outstanding, K 1,091,906
  • Annual Sales, $ 18,854 M
  • Annual Income, $ -2,150,000 K
  • 60-Month Beta 1.73
  • Price/Sales 0.49
  • Price/Cash Flow 1.83
  • Price/Book 0.61

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 23 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate 0.59
  • Number of Estimates 7
  • High Estimate 0.67
  • Low Estimate 0.53
  • Prior Year 0.55
  • Growth Rate Est. (year over year) +7.27%

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.62 +40.94%
on 10/15/19
9.60 -2.81%
on 11/11/19
+2.43 (+35.22%)
since 10/11/19
3-Month
6.07 +53.71%
on 08/15/19
9.60 -2.81%
on 11/11/19
+2.31 (+32.91%)
since 08/09/19
52-Week
6.07 +53.71%
on 08/15/19
23.97 -61.08%
on 11/13/18
-14.12 (-60.21%)
since 11/09/18

Most Recent Stories

More News
Thinking about buying stock in Aurora Cannabis, Advanced Micro Devices, General Electric, Teva Pharmaceutical, or Uber Technologies?

InvestorsObserver issues critical PriceWatch Alerts for ACB, AMD, GE, TEVA, and UBER.

AMD : 36.31 (+0.06%)
ACB.TO : 4.78 (-4.97%)
GE : 11.35 (-1.48%)
TEVA : 9.33 (+0.32%)
UBER : 27.14 (+0.48%)
Is Teva Pharmaceutical Industries Ltd. (TEVA) a Great Value Stock Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest...

TEVA : 9.33 (+0.32%)
Human Respiratory Syncytial Virus Market Scope, Research Methodology, Rising Demand, Industry Trends & Revenue Models | Major Keys: F. Hoffmann-La Roche Ltd., Merck & Co

According to a recently published report by Research Nester titled "delivers the detailed overview of the global human respiratory syncytial virus market in terms of market segmentation by product type,...

GILD : 64.64 (-1.13%)
GSK : 44.26 (-0.36%)
MRK : 83.28 (-0.37%)
TEVA : 9.33 (+0.32%)
VRX.TO : 30.80 (-3.33%)
Teva (TEVA) Q3 Earnings Miss, Stock Up on Guidance Increase

Teva Pharmaceutical (TEVA) misses earnings estimate but beats the same for sales. The company increases the lower end of its 2019 sales and earnings guidance. Shares rise.

AGN : 181.58 (+0.17%)
GSK : 44.26 (-0.36%)
MYL : 17.24 (-2.10%)
TEVA : 9.33 (+0.32%)
Teva Announces $1.5 Billion Debt Tender Offers

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that it has commenced tender offers (the "Offers") to purchase for cash for a combined aggregate purchase price (exclusive of accrued...

TEVA : 9.33 (+0.32%)
Teva Announces Launch of $1,500,000,000 Offering of Senior Notes

Teva Pharmaceutical Industries Limited (NYSE and TASE: TEVA) ("Teva") announced today the following private offering of senior notes:

TEVA : 9.33 (+0.32%)
5 Low Price-to-Book Stocks to Buy in November

P/B ratio is emerging as a convenient tool for identifying low-priced stocks that have high growth prospects.

AXL : 10.85 (-1.90%)
SNX : 118.52 (-0.59%)
TEVA : 9.33 (+0.32%)
SIG : 16.81 (-4.05%)
JKS : 15.50 (+2.38%)
Thinking about buying stock in Advanced Micro Devices, General Electric, QUALCOMM, Teva Pharmaceutical, or Uber Technologies?

InvestorsObserver issues critical PriceWatch Alerts for AMD, GE, QCOM, TEVA, and UBER.

AMD : 36.31 (+0.06%)
GE : 11.35 (-1.48%)
QCOM : 91.84 (-2.33%)
TEVA : 9.33 (+0.32%)
UBER : 27.14 (+0.48%)
Teva (TEVA) Q3 Earnings Miss, Sales Top Estimates, Stock Up

Teva Pharmaceutical (TEVA) misses earnings estimate but beats the same for sales. Shares rise in pre-market trading.

TEVA : 9.33 (+0.32%)
Teva and Celltrion Announce the Availability of TRUXIMA(R) (rituximab-abbs) Injection, the First Biosimilar to Rituxan(R) (rituximab) in the United States

Teva Pharmaceuticals USA, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), Celltrion, Inc., (KRX KRX:068270) and Celltrion Healthcare, Co., Ltd. (KRX KOSDAQ:091990),...

TEVA : 9.33 (+0.32%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Trade TEVA with:

Business Summary

TEVA Pharmaceuticals USA, the business is to develop, manufacture, and market generic pharmaceuticals. Teva USA sells its products to chains, wholesalers, distributors, hospitals, managed care entities, and government agencies. The company markets a variety of dosage forms, including both extended...

See More

Key Turning Points

2nd Resistance Point 9.77
1st Resistance Point 9.55
Last Price 9.33
1st Support Level 9.16
2nd Support Level 8.99

See More

52-Week High 23.97
Fibonacci 61.8% 17.13
Fibonacci 50% 15.02
Fibonacci 38.2% 12.91
Last Price 9.33
52-Week Low 6.07

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar